Aaron M Magnuson1, Daniel P Regan2, Andrea D Booth1, Josephine K Fouts1, Claudia M Solt1, Jessica L Hill1, Steve W Dow2, Michelle T Foster3. 1. Department of Food Science and Human Nutrition, Colorado State University, 1571 Campus Delivery, 500 West Lake Street, Fort Collins, CO, 80523, USA. 2. Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA. 3. Department of Food Science and Human Nutrition, Colorado State University, 1571 Campus Delivery, 500 West Lake Street, Fort Collins, CO, 80523, USA. michelle.foster@colostate.edu.
Abstract
PURPOSE: Accumulation of visceral, but not subcutaneous, adipose tissue is highly associated with metabolic disease. Inflammation inciting from adipose tissue is commonly associated with metabolic disease risk and comorbidities. However, constituents of the immune system, lymph nodes, embedded within these adipose depots remain under-investigated. We hypothesize that, lymph nodes are inherently distinct and differentially respond to diet-induced obesity much like the adipose depots they reside in. METHODS: Adipose tissue and lymph nodes were collected from the visceral and inguinal depots of male mice fed 13 weeks of standard CHOW or high fat diet (HFD). Immune cells were isolated from tissues, counted and characterized by flow cytometry or plated for proliferative capacity following Concanavalin A stimulation. Lymph node size and fibrosis area were also characterized. RESULTS: In HFD fed mice visceral adipose tissue accumulation was associated with significant enlargement of the lymph node encased within. The subcutaneous lymph node did not change. Compared with mice fed CHOW for 13 weeks, mice fed HFD had a decline in immune cell populations and immune cell proliferative ability, as well as, exacerbated fibrosis accumulation, within the visceral, but not subcutaneous, lymph node. CONCLUSIONS: Obesity-induced chronic low-grade inflammation is associated with impaired immunity and increased susceptibility to disease. Excessive visceral adiposity and associated inflammation driven by diet likely leads to obesity-induced immune suppression by way of lymph node/lymphatic system pathophysiology.
PURPOSE: Accumulation of visceral, but not subcutaneous, adipose tissue is highly associated with metabolic disease. Inflammation inciting from adipose tissue is commonly associated with metabolic disease risk and comorbidities. However, constituents of the immune system, lymph nodes, embedded within these adipose depots remain under-investigated. We hypothesize that, lymph nodes are inherently distinct and differentially respond to diet-induced obesity much like the adipose depots they reside in. METHODS:Adipose tissue and lymph nodes were collected from the visceral and inguinal depots of male mice fed 13 weeks of standard CHOW or high fat diet (HFD). Immune cells were isolated from tissues, counted and characterized by flow cytometry or plated for proliferative capacity following Concanavalin A stimulation. Lymph node size and fibrosis area were also characterized. RESULTS: In HFD fed mice visceral adipose tissue accumulation was associated with significant enlargement of the lymph node encased within. The subcutaneous lymph node did not change. Compared with mice fed CHOW for 13 weeks, mice fed HFD had a decline in immune cell populations and immune cell proliferative ability, as well as, exacerbated fibrosis accumulation, within the visceral, but not subcutaneous, lymph node. CONCLUSIONS:Obesity-induced chronic low-grade inflammation is associated with impaired immunity and increased susceptibility to disease. Excessive visceral adiposity and associated inflammation driven by diet likely leads to obesity-induced immune suppression by way of lymph node/lymphatic system pathophysiology.
Entities:
Keywords:
Central obesity; Lymphatics; Metabolic disease; Pro-inflammation; Visceral adiposity
Authors: Nils Halberg; Tayeba Khan; Maria E Trujillo; Ingrid Wernstedt-Asterholm; Alan D Attie; Shariq Sherwani; Zhao V Wang; Shira Landskroner-Eiger; Sean Dineen; Ulysses J Magalang; Rolf A Brekken; Philipp E Scherer Journal: Mol Cell Biol Date: 2009-06-22 Impact factor: 4.272
Authors: Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst Journal: J Exp Med Date: 2009-12-14 Impact factor: 14.307
Authors: Dennis Dwan; Seth K Ramin; Youdinghuan Chen; Kristen E Muller; Roberta M diFlorio-Alexander Journal: Cells Date: 2022-01-30 Impact factor: 6.600
Authors: Carolina F F A Costa; Benedita Sampaio-Maia; Ricardo Araujo; Diana S Nascimento; Joana Ferreira-Gomes; Manuel Pestana; Maria J Azevedo; Ines S Alencastre Journal: Nutrients Date: 2022-01-14 Impact factor: 5.717